Additionally, in an experimental mouse model with autoimmune myocarditis, treatment with spironolactone (an aldosterone receptor antagonist) significantly alleviated myocardial hypertrophy, improved cardiac function, and diminished myocardial fibrosis via inhibition of ETS1 [105]. This evidence concerns the gene ETS1 and cardiac hypertrophy.